SciELO journals
Browse
1678-9849-rsbmt-52-e20180386-gf1.jpg (306.93 kB)

Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy

Download (306.93 kB)
figure
posted on 2019-03-20, 02:48 authored by Gabriel Pacífico Seabra Nunes, Patrícia da Silva Cunha, Daniele Patrícia Dal Bosco, Sandra Lúcia Euzébio Ribeiro

Abstract Hepatitis B infection is a global health issue. When considering patients with rheumatic diseases, this is no different. By using immunosuppressant drugs, such as DMARDs and biologics, viral reactivation is possible, leading to serious consequences on the patient. We report 3 cases of association between ankylosing spondylitis and hepatitis B with the use of immunosuppressant drugs. Case 1 was a patient with previous HBV infection using DMARD. Cases 2 and 3 were patients chronically infected by HBV during immunosuppressant therapy. The management of HBV infection during immunosuppressant therapy is challenging and needs multidisciplinary support.

History

Usage metrics

    Revista da Sociedade Brasileira de Medicina Tropical

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC